REmote CArdiac MOnitoring by the Corsano CardioWatch 287-2 Evaluation Study

Completed

• Conditions: Atrial Fibrillation; Hypertension; Rhythm; Palpitations; Hypotension; Disorder

• Registration Number: NCT05899959
• Lead Sponsor: Corsano Health B.V.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-6-2
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 190

Inclusion Criteria

Inclusion Criteria:<br><br> - = 18 years old;<br><br> - able to provide consent;<br><br> - receiving EKG holter or automatic blood pressure cuff for home monitoring per doctor<br> prescription<br><br>Exclusion Criteria:<br><br> - Unable to wear the Corsano CardioWatch 287 due to reasons such as allergic<br> reactions, wounds, amputations etc.;<br><br> - Unable to receive blood pressure measurements per cuff due to lymphedema,<br> amputation, dialysis shunt, wounds, etc.;<br><br> - Pregnant women;<br><br> - Breastfeading women;<br><br> - Upper arm circumference not within the cuff range (22-42 cm)<br><br> - Unable or not willing to sign informed consent;<br><br> - Significant mental or cognitive impairment.

Exclusion Criteria

Not provided

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Atrial fibrillation detection rate;Blood pressure accuracy

Secondary Outcome Measures

Name	Time	Method
Blood pressure accuracy;Usability questionnaire